Globant S.A. GLOB R3KTECHAI
Company Overview
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development; GUT Studio, which allows clients to better connect brands; and Enterprise Studio, which leverages technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows. Further, it provides GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, for marketing, communications, and advertising, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. Globant S.A. has a strategic collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence; and Viability and Cascadience LLC to launch AI-powered platform for students with disabilities. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
Why Investors Should Care
Revenue has grown at a 11.3% CAGR over the past five years.
Trades at a P/E of 14.5, below the sector median of 29.2.
Carries low leverage with a debt-to-equity ratio of 0.24.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $2.45B (+1.6% YoY); net profit $102.92M.
- Trailing 12 Months Year-on-year growth — revenue +0.0%, earnings +25.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 11.3%, profit CAGR -11.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 11.31% |
| 1 Year: | 0.00% |
Compounded Profit Growth
| 5 Years: | -11.58% |
| 1 Year: | 25.00% |
Stock Price Performance
| 1 Year: | -53.41% |
| 6 Months: | -26.39% |
| 3 Months: | -2.75% |
| 1 Month: | -0.75% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)45.76 · Neutral
P/E of 14.50 is below the sector median of 29.22 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 11.3% over 5 years.
- Generates positive free cash flow.
CONS
- Earnings shrank at -11.6% CAGR over 5 years.
- Trading 53.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GLOB Globant S.A. R3KTECHAI | 37.12 | 14.50 | $1.60B | 0.00% | 8.17% | 5.48% | 11.31% | -11.58% |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 225.73 | 28.50 | $5.45T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 316.22 | 36.22 | $4.61T | 0.34% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 493.95 | 27.49 | $3.67T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 439.00 | 32.71 | $2.28T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 368.56 | 46.95 | $1.75T | 0.71% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,000.26 | 22.59 | $1.13T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 505.74 | 128.36 | $825.61B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,764.85 | 59.89 | $677.88B | 0.51% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 611.09M | 614.18M | 617.14M | 612.47M | 607.09M |
| Cost of Revenue | - | 397.86M | 396.54M | 402.38M | 398.81M | 397.60M |
| Gross Profit | - | 213.23M | 217.64M | 214.76M | 213.66M | 209.48M |
| Operating Expenses | - | 163.37M | 164.20M | 153.88M | 154.11M | 157.81M |
| Operating Income | - | 49.86M | 53.44M | 60.87M | 59.55M | 51.67M |
| EBITDA | - | 48.61M | 6.51M | 58.44M | 63.03M | 60.11M |
| Interest Expense | - | 9.63M | 10.97M | 10.01M | 6.84M | 9.43M |
| Pretax Income | - | 38.99M | -4.47M | 48.43M | 56.19M | 50.67M |
| Tax Provision | - | 8.49M | -742.00K | 14.24M | 13.20M | 11.90M |
| Net Income | - | 30.64M | -2.38M | 34.19M | 41.96M | 36.98M |
| Diluted EPS | - | 0.68 | -0.05 | 0.73 | 0.93 | 0.85 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 1.78B | 2.10B | 2.42B | 2.45B |
| Cost of Revenue | - | 1.11B | 1.34B | 1.55B | 1.60B |
| Gross Profit | - | 669.39M | 755.76M | 863.37M | 859.29M |
| Operating Expenses | - | 462.69M | 556.80M | 637.95M | 635.57M |
| Operating Income | - | 206.71M | 198.96M | 225.42M | 223.72M |
| EBITDA | - | 314.85M | 357.95M | 401.82M | 364.37M |
| Interest Expense | - | 14.04M | 20.07M | 28.66M | 37.45M |
| Pretax Income | - | 192.88M | 198.02M | 210.43M | 139.15M |
| Tax Provision | - | 43.41M | 39.51M | 41.43M | 35.19M |
| Net Income | - | 148.89M | 158.54M | 165.73M | 102.92M |
| Diluted EPS | - | 3.47 | 3.64 | 3.72 | 2.29 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 2.20B | 2.73B | 3.15B | 3.32B |
| Current Assets | - | 857.61M | 924.53M | 838.55M | 953.76M |
| Cash & Equivalents | - | 292.46M | 307.22M | 142.09M | 243.74M |
| Inventory | - | - | - | - | - |
| Receivables | - | 361.88M | 408.17M | 488.23M | 472.61M |
| Total Liabilities | - | 639.63M | 931.18M | 1.12B | 1.16B |
| Current Liabilities | - | 428.59M | 665.32M | 507.16M | 580.29M |
| Long Term Debt | - | 861.00K | 2.19M | 290.94M | 347.04M |
| Total Debt | - | 138.84M | 277.84M | 410.16M | 473.64M |
| Total Equity | - | 1.51B | 1.73B | 1.96B | 2.09B |
| Shares Outstanding | - | 42.43M | 43.24M | 44.20M | 44.81M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 197.52M | 318.52M | 248.73M | 301.18M |
| Investing Cash Flow | - | -269.30M | -350.36M | -403.90M | -134.51M |
| Financing Cash Flow | - | -65.68M | 44.53M | -5.81M | -64.57M |
| Capital Expenditure | - | -95.43M | -126.80M | -113.62M | -89.48M |
| Free Cash Flow | - | 102.09M | 191.72M | 135.10M | 211.69M |
| Net Change in Cash | - | -137.46M | 12.69M | -160.99M | 102.10M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 37.6% | 36.1% | 35.7% | 35.0% |
| Operating Margin % | - | 11.6% | 9.5% | 9.3% | 9.1% |
| Net Margin % | - | 8.4% | 7.6% | 6.9% | 4.2% |
| ROE % | - | 9.9% | 9.2% | 8.4% | 4.9% |
| ROCE % | - | 11.7% | 9.7% | 8.5% | 8.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 10.52% | 4.45M | $158.29M |
| 2 | Brandes Investment Partners L.P. | 9.46% | 4.00M | $142.37M |
| 3 | Pzena Investment Management LLC | 9.13% | 3.86M | $137.37M |
| 4 | Alyeska Investment Group, L.p. | 6.99% | 2.95M | $105.17M |
| 5 | Capital International Investors | 4.41% | 1.86M | $66.30M |
| 6 | Wellington Management Group, LLP | 4.04% | 1.71M | $60.72M |
| 7 | AQR Capital Management, LLC | 2.81% | 1.19M | $42.31M |
| 8 | Two Sigma Investments, LP | 2.79% | 1.18M | $41.98M |
| 9 | Morgan Stanley | 2.76% | 1.17M | $41.58M |
| 10 | Goldman Sachs Group Inc | 2.75% | 1.16M | $41.33M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GLOB
Globant SA (GLOB) Stock Down 3.0% -- Now Undervalued? GF Score: 79/100 - gurufocus.com
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPTjM3RExRV2xXSzVzSnRPU0h6b0FXU1p0eHFmMm1ENEVLMDZhYTkyVVdfR0RVVk53ZWVEcmxxTlV6eHc0aE5mRE5pb1Q1UmF2NVBqZEVEV2RxeGV6UUtacDY0dV9iUE45OFoyaWN5UmxJWjR6TGpySUJic012ejB5SGkxREg2STNvX3dTcG…
Integration migrations could shrink from months to weeks with Globant's new AI service. - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQWUFlSl9iR0pqYV9sY2o4VUV0SkwxeXkyVHowc2RXaFhXQ242N2w0VjA5cGVldEhFTlhHWjdubjNUbzRQMHlyZkZoa05rMEpoMGFUMzdRZXJ6cHhKZkY4WGsyTHp5c1hQTjY4ZnNaMy15MWo2dXE2S0V3YnlHQVNZQXp3QTFQQy1rbnh3N1…
Globant (GLOB) Stock May Still Look Cheap On Earnings Power - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOWFZvNzBReGhCTUpaU3dWRE5DeGFEVzRTblFUVFIwVGRyWjZINzNncUFvR3BFb05UcFptTGJkcVlrNzlpOXJsWHpTRFhrY0hwWkgzcmFPZ1hCU2YyaDRCcHlPWXdPdWkxVmNicXZxSGpZOXN2WElWNWU0aHMycmhiR2RTY0JFY0dKR1N2bl…
Globant S.A. (GLOB) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxNbEUzd2JxM1JyNGF2d2RSMGVRcU1vMXlOMnNnZ3Vfc1ZKSk9DYXYtY2ktVzlqTlJaWXBvZlJPZG9QZUtpdVNpSjVYNkJ1QnZXUDMtWGZCajM3eDlQSWYyX0psNnNPUlYzNVc4OHFIMnhvdEIzbG9lYjBQekpvTTBQVENROWpqN0czZGtKQw…
Globant (NYSE:GLOB) Stock Rating Lowered by Zacks Research - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOVzFtNjZJckNnV19pTU16amRBR3NoV09iVlRDOWxjTW1rZnEyUW9scExoMEN1dTdhTmE5TVdTRlNmUTVxdEtGZ0xJQmFBMnBvTjQ3aGx1TlFDaGlWeEFQa3hZci1wWmhKYmliaU9uUDJpTlBqVU1QYzhtTjFJQl9kbDhwcTRaRVVSZzhDWm…
Globant (GLOB) Securities Investigation Notice - Levi & Korsinsky - PR Newswire
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNR0twVE5ibmM3am1sU01RNzVvcTh2Y193Zkw1dGZVUkVTYUcwQnY4azFqMV9TTGZBMWZGeHdDYktBcnU2T0dRTXJhYlNfWUxCaFNuZWJVbDJPUjVBejNZT2VxMFJZbTJ3RVlUdmcyQ0l1X3dSQktTaGs0aWpsQVQxaDlRYk1mcGo0UWZVWX…
GLOB — Frequently Asked Questions
What is the current share price of Globant S.A. (GLOB)?
As of 2026-09-19 21:16 PDT, Globant S.A. (GLOB) trades at $37.12 on NYSE. Its 52-week range is $27.73 to $79.67.
What is the market capitalisation of GLOB?
Globant S.A. (GLOB) has a market capitalisation of $1.60B on NYSE.
What is the P/E ratio of GLOB?
GLOB trades at a trailing price-to-earnings (P/E) ratio of 14.50. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 0.72.
What is the return on equity (ROE) of GLOB?
GLOB has a return on equity (ROE) of 5.48%. Its return on capital employed (ROCE) is 8.17%.
Is GLOB a good stock to buy?
This page provides a data-driven analysis of Globant S.A. (GLOB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.